
From Cancer waiting times 1 January to 31 March 2026 published today:
There were 4,668 eligible referrals where the 62-day standard applied, a decrease of 2.7% from the previous quarter, but an increase of 25.4% from the quarter ending 31 December 2019, the last full quarter pre‑pandemic. 72.2% of patients started treatment within 62 days, compared with 72.6% in the previous quarter.
There were 7,225 eligible referrals where the 31-day standard applied, a decrease of 2.0% from the previous quarter, but an increase of 13.1% from the quarter ending 31 December 2019. 94.5% of patients started treatment within 31 days, compared with 95.6% in the previous quarter, and 96.5% in the quarter ending 31 December 2019.
Before we go any further, see a big news story there being total ignored? There were 25.4% more referred under the 62-day standard and 13.1% more referred under the 31-day standard than had been in the days before the pandemic at the end of 2019. Performance at the end of 2019 had been 83.7% and 96.5%. They had 25% and 13% fewer patients and yet did not perform, I’d guess, 25% and 13% better.
NHS England does not publish quarterly data for comparison but does provide annual figures:
For NHS England:
62-day Combined Standard – 12-month average for 2025: 69.4% .
31-day Combined Standard 12-month average for 2025: 91.8%.
NHS Scotland annual data can be produced from the supplementary file table and from them we get for 2025, 70.5% and 95% respectively.
Analysis
BBC Scotland and many ornery Joes will say there is little difference there but even the 1.1 difference for the 62-day target is 1% of the around 20 000 who were referred – 200 people who were treated on time who would not have been had they lived in England.
As for the 31-day target, that 3.2% is of around 30 000 referred or 10 000 who were treated on time who would not have been had they lived in England.
Sources:
Discover more from The 'Unstoppable' Talking-up Scotland
Subscribe to get the latest posts sent to your email.
